Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

COVID-19 may cause hair loss due to infection stress or treatments.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Teen hair loss common in boys, linked to family history and mild symptoms.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Successful surgical hair restoration requires careful planning, precise execution, and proper aftercare, using techniques like follicular unit transplantation and correct hair angling for best cosmetic results.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Isotretinoin may cause hair loss, especially in women and young adults.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.